Blood cancers

Why QOL needs to feature more in haematological cancer trials

Quality of life deserves more attention in haematological malignancies – in the design and reporting of trials, in registries and in clinical practice where it needs to be a bigger part of the conversation. The limbic spoke to two clinician-researchers with an interest in raising the profile of quality of life in research and practice. ...

Already a member?

Login to keep reading.

© 2021 the limbic